-
公开(公告)号：US07906146B2
公开(公告)日：2011-03-15
申请号：US12389509
申请日：2009-02-20
CPC分类号： C07K14/605 , A61K38/00 , A61K38/16 , A61K38/26 , A61K47/48215 , A61K47/60 , C07K14/57563
摘要： Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided.
摘要翻译： 提供了含有毒蜥外泌肽，毒蜥外泌肽激动剂和/或毒蜥外泌肽类似物的新型制剂。
-
公开(公告)号：US6114304A
公开(公告)日：2000-09-05
申请号：US302069
申请日：1994-09-07
IPC分类号： A61K45/00 , A61K35/39 , A61K38/22 , A61K38/23 , A61K49/00 , A61P1/00 , A61P1/14 , A61P3/10 , A61P25/02 , A61P43/00 , C07K14/585 , A61K37/02 , C07K7/10 , C07K7/36
CPC分类号： A61K38/23 , A61K38/22 , Y10S514/866
摘要： Methods for treating conditions associated with elevated, inappropriate or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an amylin agonist alone or in conjunction with other anti-gastric emptying agents. Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are also described.
-
公开(公告)号：US20080249018A1
公开(公告)日：2008-10-09
申请号：US12100880
申请日：2008-04-10
IPC分类号： A61K38/22
CPC分类号： C07K14/605 , A61K38/00 , A61K38/16 , A61K38/26 , A61K47/60 , C07K14/57563
摘要： Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided
摘要翻译： 提供了含有毒蜥外泌肽，毒蜥外泌肽激动剂和/或毒蜥外泌肽类似物的新型制剂
-
公开(公告)号：US06902744B1
公开(公告)日：2005-06-07
申请号：US09889330
申请日：2000-01-14
IPC分类号： A61K9/08 , A61K20060101 , A61K9/14 , A61K9/19 , A61K38/00 , A61K38/17 , A61K38/22 , A61K38/26 , A61K47/02 , A61K47/10 , A61K47/12 , A61K47/18 , A61K47/26 , A61K47/34 , A61P20060101 , A61P3/04 , A61P3/10 , A61P5/50 , C07K14/575
CPC分类号： A61K38/2278 , Y10S514/866
摘要： Novel exendin and exendin agonist compound formulations and dosages and methods of administration thereof are provided. These compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
摘要翻译： 提供了新的毒蜥外泌肽和毒蜥外泌激素化合物制剂及其给药方法和给药方法。 这些组合物和方法可用于治疗通过降低血浆葡萄糖或延迟和/或减缓胃排空或抑制食物摄取而受益的糖尿病和病症。
-
公开(公告)号：US06608029B1
公开(公告)日：2003-08-19
申请号：US09576062
申请日：2000-05-22
IPC分类号： A61K3810
CPC分类号： A61K38/23 , A61K38/22 , Y10S514/866
摘要： Methods for treating conditions associated with elevated, inappropriate or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an amylin agonist alone or in conjunction with other anti-gastric emptying agents. Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are also described.
摘要翻译： 公开了用于治疗与升高的，不适当的或不期望的餐后血糖水平相关的病症的方法，其包括单独施用有效量的胰岛淀粉样多肽激动剂或与其他抗胃排空剂联合施用。 还描述了用于减少胃动力和延迟胃排空用于治疗和诊断目的的方法。
-
公开(公告)号：US5795861A
公开(公告)日：1998-08-18
申请号：US471675
申请日：1995-06-05
IPC分类号： A61K45/00 , A61K35/39 , A61K38/22 , A61K38/23 , A61K49/00 , A61P1/00 , A61P1/14 , A61P3/10 , A61P25/02 , A61P43/00 , C07K14/585 , A61K38/00 , C04K5/00 , C04K7/00
CPC分类号： A61K38/23 , A61K38/22 , Y10S514/866
摘要： Methods for treating conditions associated with elevated, inappropriate or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an amylin agonist alone or in conjunction with other anti-gastric emptying agents. Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are also described.
-
公开(公告)号：US20120196799A1
公开(公告)日：2012-08-02
申请号：US13445803
申请日：2012-04-12
CPC分类号： A61K38/22
摘要： Methods for treating obesity are disclosed which comprise administration of a therapeutically effective amount of an amylin or an amylin agonist alone or in conjunction with another obesity relief agent. Additionally, methods for reducing insulin-induced weight gain are disclosed which comprise administration of a therapeutically effective amount of an amylin or an amylin agonist.
摘要翻译： 公开了治疗肥胖症的方法，其包括单独施用治疗有效量的胰岛淀粉样多肽或胰岛淀粉样多肽激动剂或与另一种肥胖症缓解剂联合施用。 此外，公开了减少胰岛素诱导的体重增加的方法，其包括施用治疗有效量的胰岛淀粉样多肽或胰岛淀粉样多肽激动剂。
-
公开(公告)号：US06417164B1
公开(公告)日：2002-07-09
申请号：US09707370
申请日：2000-11-06
IPC分类号： A61K3810
CPC分类号： A61K38/22 , A61K38/23 , Y10S514/866
摘要： Methods for treating non-insulin-taking Type II diabetes mellitus which comprise administering a therapeutically effective amount of an amylin agonist.
摘要翻译： 用于治疗非胰岛素摄取II型糖尿病的方法，其包括施用治疗有效量的胰岛淀粉样多肽激动剂。
-
9.发明申请Methods for Lowering Plasma Glucagon with Exendins and Exendin Agonist Analogs 审中-公开降低血浆胰高血糖素与毒蜥外泌肽激素类似物的方法公开(公告)号：US20110281798A1
公开(公告)日：2011-11-17
申请号：US13045334
申请日：2011-03-10
CPC分类号： C07K14/605 , A61K38/00 , A61K38/16 , A61K38/26 , A61K47/60 , C07K14/57563
摘要： Novel formulations containing exendins, exendin agonists and/or exendin analogs are provided.
摘要翻译： 提供了含有毒蜥外泌肽，毒蜥外泌肽激动剂和/或毒蜥外泌肽类似物的新型制剂。
-
公开(公告)号：US07910548B2
公开(公告)日：2011-03-22
申请号：US08870762
申请日：1997-06-06
CPC分类号： A61K38/22 , Y10S514/909
摘要： Methods for treating obesity are disclosed which comprise administration of a therapeutically effective amount of an amylin or an amylin agonist alone or in conjunction with another obesity relief agent.
摘要翻译： 公开了治疗肥胖症的方法，其包括单独施用治疗有效量的胰岛淀粉样多肽或胰岛淀粉样多肽激动剂或与另一种肥胖症缓解剂联合施用。
-
-
-
-
-
-
-
-
-
搜索结果
14 条记录 (耗时 0.018 秒)
